A blood-based mRNA signature distinguishes people with Long COVID from recovered individuals

IntroductionLong COVID is a debilitating condition that lasts for more than three months post-infection by SARS–CoV–2. On average, one in ten individuals infected with SARS CoV- 2 develops Long COVID worldwide. A knowledge gap exists in our understanding of the mechanisms, genetic risk factors, and...

Full description

Saved in:
Bibliographic Details
Main Authors: Daniel Missailidis, Esmaeil Ebrahimie, Manijeh Mohammadi Dehcheshmeh, Claire Allan, Oana Sanislav, Paul Fisher, Stephanie Gras, Sarah J. Annesley
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-12-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1450853/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846142726603538432
author Daniel Missailidis
Esmaeil Ebrahimie
Esmaeil Ebrahimie
Manijeh Mohammadi Dehcheshmeh
Claire Allan
Oana Sanislav
Paul Fisher
Stephanie Gras
Stephanie Gras
Stephanie Gras
Sarah J. Annesley
author_facet Daniel Missailidis
Esmaeil Ebrahimie
Esmaeil Ebrahimie
Manijeh Mohammadi Dehcheshmeh
Claire Allan
Oana Sanislav
Paul Fisher
Stephanie Gras
Stephanie Gras
Stephanie Gras
Sarah J. Annesley
author_sort Daniel Missailidis
collection DOAJ
description IntroductionLong COVID is a debilitating condition that lasts for more than three months post-infection by SARS–CoV–2. On average, one in ten individuals infected with SARS CoV- 2 develops Long COVID worldwide. A knowledge gap exists in our understanding of the mechanisms, genetic risk factors, and biomarkers that could be associated with Long COVID.MethodsIn this pilot study we used RNA-Seq to quantify the transcriptomes of peripheral blood mononuclear cells isolated from COVID-recovered individuals, seven with and seven without Long COVID symptoms (age- and sex-matched individuals), on average 6 months after infection.ResultsSeventy genes were identified as significantly up- or down-regulated in Long COVID samples, and the vast majority were downregulated. The most significantly up- or downregulated genes fell into two main categories, either associated with cell survival or with inflammation. This included genes such as ICOS (FDR p = 0.024) and S1PR1 (FDR p = 0.019) that were both up-regulated, indicating that a pro-inflammatory state is sustained in Long COVID PBMCs compared with COVID recovered PBMCs. Functional enrichment analysis identified that immune-related functions were expectedly predominant among the up- or down-regulated genes. The most frequently downregulated genes in significantly altered functional categories were two leukocyte immunoglobulin like receptors LILRB1 (FDR p = 0.005) and LILRB2 (FDR p = 0.027). PCA analysis demonstrated that LILRB1 and LILRB2 expression discriminated all of the Long COVID samples from COVID recovered samples.DiscussionDownregulation of these inhibitory receptors similarly indicates a sustained pro-inflammatory state in Long COVID PBMCs. LILRB1 and LILRB2 should be validated as prospective biomarkers of Long COVID in larger cohorts, over time and against clinically overlapping conditions.
format Article
id doaj-art-cf0b6f2b174548eaad3a4d2aaf8c0a3f
institution Kabale University
issn 1664-3224
language English
publishDate 2024-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj-art-cf0b6f2b174548eaad3a4d2aaf8c0a3f2024-12-03T06:31:00ZengFrontiers Media S.A.Frontiers in Immunology1664-32242024-12-011510.3389/fimmu.2024.14508531450853A blood-based mRNA signature distinguishes people with Long COVID from recovered individualsDaniel Missailidis0Esmaeil Ebrahimie1Esmaeil Ebrahimie2Manijeh Mohammadi Dehcheshmeh3Claire Allan4Oana Sanislav5Paul Fisher6Stephanie Gras7Stephanie Gras8Stephanie Gras9Sarah J. Annesley10Department of Microbiology, Anatomy, Physiology and Pharmacology, La Trobe University, Bundoora, VIC, AustraliaGenomics Research Platform, School of Agriculture, Biomedicine and Environment, La Trobe University, Bundoora, VIC, AustraliaSchool of Animal and Veterinary Sciences, Faculty of Sciences, Engineering and Technology, University of Adelaide, Adelaide, SA, AustraliaGenomics Research Platform, School of Agriculture, Biomedicine and Environment, La Trobe University, Bundoora, VIC, AustraliaDepartment of Microbiology, Anatomy, Physiology and Pharmacology, La Trobe University, Bundoora, VIC, AustraliaDepartment of Microbiology, Anatomy, Physiology and Pharmacology, La Trobe University, Bundoora, VIC, AustraliaDepartment of Microbiology, Anatomy, Physiology and Pharmacology, La Trobe University, Bundoora, VIC, AustraliaInfection & Immunity Program, La Trobe Institute for Molecular Science (LIMS), La Trobe University, Bundoora, VIC, AustraliaDepartment of Biochemistry and Chemistry, School of Agriculture, Biomedicine and Environment, La Trobe University, Bundoora, VIC, AustraliaDepartment of Biochemistry and Molecular Biology, Monash University, Clayton, VIC, AustraliaDepartment of Microbiology, Anatomy, Physiology and Pharmacology, La Trobe University, Bundoora, VIC, AustraliaIntroductionLong COVID is a debilitating condition that lasts for more than three months post-infection by SARS–CoV–2. On average, one in ten individuals infected with SARS CoV- 2 develops Long COVID worldwide. A knowledge gap exists in our understanding of the mechanisms, genetic risk factors, and biomarkers that could be associated with Long COVID.MethodsIn this pilot study we used RNA-Seq to quantify the transcriptomes of peripheral blood mononuclear cells isolated from COVID-recovered individuals, seven with and seven without Long COVID symptoms (age- and sex-matched individuals), on average 6 months after infection.ResultsSeventy genes were identified as significantly up- or down-regulated in Long COVID samples, and the vast majority were downregulated. The most significantly up- or downregulated genes fell into two main categories, either associated with cell survival or with inflammation. This included genes such as ICOS (FDR p = 0.024) and S1PR1 (FDR p = 0.019) that were both up-regulated, indicating that a pro-inflammatory state is sustained in Long COVID PBMCs compared with COVID recovered PBMCs. Functional enrichment analysis identified that immune-related functions were expectedly predominant among the up- or down-regulated genes. The most frequently downregulated genes in significantly altered functional categories were two leukocyte immunoglobulin like receptors LILRB1 (FDR p = 0.005) and LILRB2 (FDR p = 0.027). PCA analysis demonstrated that LILRB1 and LILRB2 expression discriminated all of the Long COVID samples from COVID recovered samples.DiscussionDownregulation of these inhibitory receptors similarly indicates a sustained pro-inflammatory state in Long COVID PBMCs. LILRB1 and LILRB2 should be validated as prospective biomarkers of Long COVID in larger cohorts, over time and against clinically overlapping conditions.https://www.frontiersin.org/articles/10.3389/fimmu.2024.1450853/fullCOVID-19Long COVIDbiomarkertranscriptomicsinflammationLILRB1
spellingShingle Daniel Missailidis
Esmaeil Ebrahimie
Esmaeil Ebrahimie
Manijeh Mohammadi Dehcheshmeh
Claire Allan
Oana Sanislav
Paul Fisher
Stephanie Gras
Stephanie Gras
Stephanie Gras
Sarah J. Annesley
A blood-based mRNA signature distinguishes people with Long COVID from recovered individuals
Frontiers in Immunology
COVID-19
Long COVID
biomarker
transcriptomics
inflammation
LILRB1
title A blood-based mRNA signature distinguishes people with Long COVID from recovered individuals
title_full A blood-based mRNA signature distinguishes people with Long COVID from recovered individuals
title_fullStr A blood-based mRNA signature distinguishes people with Long COVID from recovered individuals
title_full_unstemmed A blood-based mRNA signature distinguishes people with Long COVID from recovered individuals
title_short A blood-based mRNA signature distinguishes people with Long COVID from recovered individuals
title_sort blood based mrna signature distinguishes people with long covid from recovered individuals
topic COVID-19
Long COVID
biomarker
transcriptomics
inflammation
LILRB1
url https://www.frontiersin.org/articles/10.3389/fimmu.2024.1450853/full
work_keys_str_mv AT danielmissailidis abloodbasedmrnasignaturedistinguishespeoplewithlongcovidfromrecoveredindividuals
AT esmaeilebrahimie abloodbasedmrnasignaturedistinguishespeoplewithlongcovidfromrecoveredindividuals
AT esmaeilebrahimie abloodbasedmrnasignaturedistinguishespeoplewithlongcovidfromrecoveredindividuals
AT manijehmohammadidehcheshmeh abloodbasedmrnasignaturedistinguishespeoplewithlongcovidfromrecoveredindividuals
AT claireallan abloodbasedmrnasignaturedistinguishespeoplewithlongcovidfromrecoveredindividuals
AT oanasanislav abloodbasedmrnasignaturedistinguishespeoplewithlongcovidfromrecoveredindividuals
AT paulfisher abloodbasedmrnasignaturedistinguishespeoplewithlongcovidfromrecoveredindividuals
AT stephaniegras abloodbasedmrnasignaturedistinguishespeoplewithlongcovidfromrecoveredindividuals
AT stephaniegras abloodbasedmrnasignaturedistinguishespeoplewithlongcovidfromrecoveredindividuals
AT stephaniegras abloodbasedmrnasignaturedistinguishespeoplewithlongcovidfromrecoveredindividuals
AT sarahjannesley abloodbasedmrnasignaturedistinguishespeoplewithlongcovidfromrecoveredindividuals
AT danielmissailidis bloodbasedmrnasignaturedistinguishespeoplewithlongcovidfromrecoveredindividuals
AT esmaeilebrahimie bloodbasedmrnasignaturedistinguishespeoplewithlongcovidfromrecoveredindividuals
AT esmaeilebrahimie bloodbasedmrnasignaturedistinguishespeoplewithlongcovidfromrecoveredindividuals
AT manijehmohammadidehcheshmeh bloodbasedmrnasignaturedistinguishespeoplewithlongcovidfromrecoveredindividuals
AT claireallan bloodbasedmrnasignaturedistinguishespeoplewithlongcovidfromrecoveredindividuals
AT oanasanislav bloodbasedmrnasignaturedistinguishespeoplewithlongcovidfromrecoveredindividuals
AT paulfisher bloodbasedmrnasignaturedistinguishespeoplewithlongcovidfromrecoveredindividuals
AT stephaniegras bloodbasedmrnasignaturedistinguishespeoplewithlongcovidfromrecoveredindividuals
AT stephaniegras bloodbasedmrnasignaturedistinguishespeoplewithlongcovidfromrecoveredindividuals
AT stephaniegras bloodbasedmrnasignaturedistinguishespeoplewithlongcovidfromrecoveredindividuals
AT sarahjannesley bloodbasedmrnasignaturedistinguishespeoplewithlongcovidfromrecoveredindividuals